Lexaria Bioscience Corp. (LEXX) Ownership
LEXX ownership summary
as of October 18, 2026- Institutions
- 5.1% of shares outstanding
- Insiders
- 2.60% of shares outstanding
- Shares outstanding
- 2.1M
- Float
- 1.6M shares available to trade
- Short interest
- 13.43% 275K shares short
- Days to cover
- 2.68 short interest up 53.4% vs prior month
- Institutions 5.07%
- Insiders 2.60%
- Other investors 92.33%
LEXX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Invenomic Capital Management, LP | 1.39% | 346K | $988,659 | −96,616 (−21.8%) | June 30, 2026 |
| 2 | Vanguard Capital Management, LLC | 1.20% | 298K | $853,527 | +76,143 (+34.3%) | June 30, 2026 |
| 3 | Geode Capital Management, LLC | 1.01% | 250K | $716,187 | −43,742 (−14.9%) | June 30, 2026 |
| 4 | Citadel Advisors Llc | 0.63% | 157K | $448,863 | +143,432 (+1,061.4%) | June 30, 2026 |
| 5 | The Toronto-Dominion Bank | 0.40% | 100K | $286,037 | −40,000 (−28.6%) | June 30, 2026 |
| 6 | Vanguard Fiduciary Trust Co | 0.38% | 94K | $269,315 | — | June 30, 2026 |
| 7 | HRT FINANCIAL LLC | 0.26% | 65K | $186,040 | +46,584 (+252.3%) | June 30, 2026 |
| 8 | UBS Group AG | 0.19% | 47K | $134,323 | −5,742 (−10.9%) | June 30, 2026 |
| 9 | Northern Trust Corp | 0.16% | 40K | $113,900 | +21,436 (+116.6%) | June 30, 2026 |
| 10 | State Street Corp | 0.16% | 39K | $112,401 | — | June 30, 2026 |
| 11 | BlackRock Inc | 0.11% | 27K | $78,493 | — | June 30, 2026 |
| 12 | StoneX Group Inc | 0.10% | 26K | $73,542 | +25,714 (0.0%) | June 30, 2026 |
| 13 | Krilogy Advisors LLC | 0.10% | 24K | $69,078 | +4,500 (+22.9%) | June 30, 2026 |
| 14 | XTX Topco Ltd | 0.09% | 22K | $63,772 | −2,769 (−11.0%) | June 30, 2026 |
| 15 | Virtu Financial LLC | 0.08% | 19K | $54,057 | +18,901 (0.0%) | June 30, 2026 |
| 16 | Renaissance Technologies Corp | 0.07% | 16K | $47,190 | +200 (+1.2%) | June 30, 2026 |
| 17 | Susquehanna International Group, LLP | 0.06% | 15K | $43,652 | +15,263 (0.0%) | June 30, 2026 |
| 18 | Vontobel Holding Ltd. | 0.06% | 15K | $43,441 | −7,811 (−34.0%) | June 30, 2026 |
| 19 | Bank of Montreal | 0.06% | 14K | $40,134 | — | June 30, 2026 |
| 20 | BMO Capital Markets Corp. | 0.06% | 14K | $40,134 | — | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 9 holders added 352K shares and 6 cut 197K.
LEXX top mutual fund and ETF holders
6 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Invenomic Institutional | 0.40% | 100K | $285,960 | −81,453 (−44.9%) | July 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.52% | 8,645 | $24,725 | −49 (−0.6%) | August 31, 2026 |
| 3 | Fidelity Series Total Market Index | 0.13% | 2,126 | $6,080 | — | August 31, 2026 |
| 4 | Fidelity Total Market Index | 0.10% | 1,742 | $4,982 | −1 (−0.1%) | August 31, 2026 |
| 5 | Vanguard U.S. Eq Idx £ Acc | 0.04% | 680 | $1,945 | — | August 31, 2026 |
| 6 | Fidelity Nasdaq Composite Index | 0.04% | 591 | $1,690 | −1 (−0.2%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LEXX insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-30 | Christopher Bunka | Buy | $0.91 | 11,900 | $10,829 |
| 2025-07-29 | Christopher Bunka | Buy | $0.92 | 15,600 | $14,352 |
| 2025-07-29 | John Martin Docherty | Buy | $0.93 | 5,376 | $5,000 |
| 2025-07-29 | Richard Christopher | Buy | $0.91 | 15,000 | $13,650 |
| 2025-07-29 | Vanessa Carle | Buy | $0.91 | 750 | $682 |
| 2025-07-29 | William Edward Mckechnie | Buy | $0.91 | 5,000 | $4,550 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LEXX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LEXX
Institutional investors own 5.1% of Lexaria Bioscience's shares and insiders 2.60%. The largest holder is Invenomic Capital Management, LP with 1.39% of the shares (346K), as of June 30, 2026. Among the top 20 institutions, 9 added shares and 6 reduced their stake in the latest filings. Short interest is 13.43% of the float, or 2.68 days of average trading volume. The share count rose 2,395.8% since 2014.
Related: LEXX analyst forecast, LEXX key metrics. See the LEXX stock overview for the latest quote and news.
LEXX ownership FAQ
Who owns the most Lexaria Bioscience stock?
The largest shareholders of Lexaria Bioscience are Invenomic Capital Management, LP (1.39%), Vanguard Capital Management, LLC (1.20%), Geode Capital Management, LLC (1.01%), Citadel Advisors Llc (0.63%), The Toronto-Dominion Bank (0.40%).
What percentage of Lexaria Bioscience is owned by institutions?
Institutions hold 5.1% of Lexaria Bioscience's shares outstanding; insiders hold 2.60%.
Which funds own Lexaria Bioscience?
The largest fund holders of Lexaria Bioscience are Invenomic Institutional (0.40%), Fidelity Extended Market Index (0.52%), Fidelity Series Total Market Index (0.13%), Fidelity Total Market Index (0.10%), Vanguard U.S. Eq Idx £ Acc (0.04%).
What is Lexaria Bioscience's short interest?
275K shares of Lexaria Bioscience were sold short, 13.43% of the float; at the average daily volume it would take 2.68 days to cover.
Are insiders buying or selling Lexaria Bioscience?
Of the latest 6 reported insider transactions in Lexaria Bioscience (since July 29, 2025), 6 were purchases and 0 were sales.
How many shares of Lexaria Bioscience are outstanding?
Lexaria Bioscience has 2.1M shares outstanding, of which 1.6M are in the public float.